|
|
Head and Neck Cancer
|
|
Head and Neck Cancer
[an error occurred while processing this directive]
ImClone drug extends life in head and neck cancer Nov 16, 2005
...said on Wednesday that a late-stage trial of its cancer drug Erbitux showed patients with head and neck cancer lived an average of 19.7 months longer than ...
- ABC News
ImClone drug extends life in head and neck cancer Nov 16, 2005
...(IMCL.O: Quote, Profile, Research) said on Wednesday that a late-stage trial of its cancer drug Erbitux showed patients with head and neck cancer lived an ...
- Reuters
First Oncolytic Viral Therapy Approved for Head and Neck Cancer Nov 17, 2005
...used in combination with chemotherapy as a treatment for patients with late stage refractory Nasopharyngeal cancer, a type of head and neck cancer prevalent in ...
- Genetic Engineering News,
Latest Data on Marked Survival Improvement with Erbitux® in Head ... Nov 22, 2005
...of Erbitux® (cetuximab) to radiation therapy improved survival by nearly 20 months compared to radiation therapy alone in the treatment of head and neck cancer ...
- Cancer Consultants (press release),
Recycled Or Revamped Therapeutics Find Novel Anti-cancer ... Nov 20, 2005
Head and neck cancer is the sixth most common cancer world wide and in the United States there are approximately 40,000 new cases diagnosed annually and 10,000 ...
- Science Daily (press release)
Tumor Protein Predicts Response of Head and Neck Cancer to ... Nov 3, 2005
...albumin-binding protein known as SPARC (Secreted Protein Acidic Rich in Cysteine) are highly associated with the response of head and neck cancer to treatment ...
- Cancer Consultants (press release),
Treatments for Head and Neck Cancer Result in Similar Quality of ... Oct 25, 2005
NEW YORK OCT 24, 2005 (Reuters Health) - The difference in quality of life (QOL) between head and neck cancer patients who undergo surgery and those who opt ...
- Cancerpage.com,
UPDATE 1-ImClone drug extends life in head, neck cancer patients Nov 16, 2005
...(IMCL.O: Quote, Profile, Research) said on Wednesday that a late-stage trial of its cancer drug Erbitux showed patients with head and neck cancer lived an ...
- Reuters
Merck KGaA: Independent Review Confirms Erbitux Improves Overall ... Nov 16, 2005
...and over.(1) Head and neck cancers are linked to tobacco and alcohol use.(2) In Europe , approximately 100,000 new cases of head and neck cancer are diagnosed ...
- PharmaLive.com (press release),
ERBITUX(R) Data on Locoregional Control and Overall Survival in ... Nov 16, 2005
According to the American Cancer Society, approximately 40,000 Americans will be diagnosed with head and neck cancer this year, including cancers of the tongue ...
- Genetic Engineering News,
Clinical Studies in the Pipeline Nov 16, 2005
However, researchers are now finding that many head and neck cancer cells overexpress a protein called the epidermal growth factor receptor (EGFR), which may ...
- Newswise (press release)
Imclone Study Shows Head Cancer Benefit Nov 16, 2005
...said Wednesday that its Erbitux cancer drug combined with radiation significantly held the spread of head and neck cancer in check and improved survival in a ...
- Forbes
Scene & Heard: Local gardeners visit Reece Center Nov 22, 2005
Other awards received by Luther in the past include the Axel Dietrichson Award from the Yul Bryner Head and Neck Cancer Foundation, the Clinical Nurse ...
- Gainesville Times,
Published Study Shows Benefits of Inovio's Selective ... Nov 18, 2005
Inovio is moving its lead product, the MedPulser(R), through pre-marketing studies for head and neck cancer and skin cancers in Europe, where it has CE Mark ...
- Genetic Engineering News,
Ethyol® Improves Dry Mouth Without Affecting Survival in Head and ... Nov 14, 2005
...amifostine) protects against xerostomia (abnormally dry mouth) while not affecting long-term outcomes in patients with head and neck cancer who undergo ...
- Cancer Consultants (press release),
With Cancer, Treatment Is Only Part of the Picture Nov 21, 2005
Patients have a right to know beforehand if surgery planned for head and neck cancer is likely to affect their ability to speak, swallow or breathe, or, for ...
- New York Times,
Erbitux Extends Life in Head-and-Neck Cancer Patients Nov 17, 2005
...said on Wednesday that a late-stage trial of its cancer drug Erbitux (cetuximab) showed patients with head-and-neck cancer lived an average of 19.7 months ...
- Cancerpage.com,
Erbitux Proven Effective in Locoregional Squamous Cell Carcinoma ... Nov 17, 2005
...[Presentation title: Cetuximab Improves Locoregional Control And Survival Of Locoregionally Advanced Head And Neck Cancer: Independent Review Of Mature Data ...
- DG News
Erbitux Gets Priority Status for Head, Neck Cancer Review Oct 31, 2005
The FDA will review Erbitux as a treatment for head and neck cancer within six months instead of the usual 10. ImClone Systems Inc. ...
- Daily News Central,
Virus to fight cancer Nov 21, 2005
The Chinese company, Shanghai Sunway Biotech, has approval to market H101 to treat head and neck cancer, according to the Times. – (HealthDayNews).
- Health24.com,
China Approves a Selective Cancer Drug Nov 16, 2005
The company, Shanghai Sunway Biotech, received clearance to sell its drug, H101, in China as a treatment for a type of head and neck cancer, according to a ...
- New York Times,
Viventia receives Fast Track designation from the FDA for ... Nov 10, 2005
..."Recurrent, refractory head and neck cancer is a devastating and aggressive disease for which there are limited treatment options," said Dr. Nick Glover ...
- PR Newswire (press release),
Merck KGaA's Erbitux phase III trial for cancer shows improved ... Nov 16, 2005
...cancer drug Erbitux used in combination with radiotherapy showed that it improved median survival in patients suffering from head and neck cancer by 19.7 months ...
- Forbes
It's Never Too Late to Quit Smoking: Dana-Farber Expert Offers ... Nov 16, 2005
...smoking in their 60s, 70s, and 80s benefit by reducing their risk of dying from a heart attack or from developing lung or head and neck cancer, says Johnson.
- AScribe
Cetuximab clinical trial programme accelerates Nov 5, 2005
...on 30 August 2005 to Swissmedic and the European Medicines Agency (EMEA) for approval to extend the use of cetuximab in the treatment of head and neck cancer. ...
- Medical News Today (press release),
Viventia Biotech reports third quarter 2005 results Nov 14, 2005
...and Health Canada to begin a Phase II study evaluating Proxinium(TM) for the treatment of patients with chemotherapy-refractory recurrent head and neck cancer. ...
- Yahoo! News (press release)
Survival Boost for Head and Neck Cancers Oct 23, 2005
Researchers studied patients with recurrent squamous-cell head and neck cancer or a second tumor that had developed in a previously radiated area. ...
- Ivanhoe,
Health notes Nov 9, 2005
CancerCare will address the multidisciplinary approach to living with head and neck cancer during its Tuesday telephone education workshop. ...
- Blue Springs Examiner,
Fighting For A Miracle Nov 13, 2005
Senay reports. Frank Burrough's daughter Abigail was diagnosed with head and neck cancer at age 18. She died three years later. He ...
- CBS News
UCF to host laryngectomy conference Nov 14, 2005
Alan George, Head of Care Services at UCF, said the conference would cover a wide range of topics of interest to those affected by head and neck cancer. ...
- 4ni.co.uk,
40-60 persons diagnosed with lung cancer in Kuwait every year: Dr ... Nov 12, 2005
...lung cancer constitutes 13 percent of all cancer cases, and is the fourth most widely spread in Kuwait after lymphatic cancer, leukemia and head and neck cancer ...
- Arab Times,
Dr. Paul Nemiroff Nov 8, 2005
Dr. Nemiroff, who specializes in head and neck cancer and reconstructive surgery, received his MD from UCLA Medical School with surgical residencies at UCLA ...
- KDKA,
FDA Accepts ERBITUX(R) (Cetuximab) sBLA Submission for the ... Oct 31, 2005
The application seeks approval for use ofERBITUX in combination with radiation for locally or regionallyadvanced head and neck cancer, and as monotherapy in ...
- Finanzen.net,
Key to Improved Chemotherapy Response to ABRAXANE(TM) Validated by ... Nov 3, 2005
Symposium XXIII on several studies of ABRAXANE, including non-small cell lung cancer, metastatic malignant melanoma and head and neck cancer, showing high ...
- Yahoo! News (press release)
Cetuximab to be Considered for the Treatment of Squamous Cell ... Oct 31, 2005
The application seeks approval for use of ERBITUX in combination with radiation for locally or regionally advanced head and neck cancer, and as monotherapy in ...
- RxPG NEWS,
Key to Improved Chemotherapy Response to ABRAXANE(TM) Validated by ... Nov 3, 2005
...secreted protein SPARC and enhanced antitumor activity of albumin-bound paclitaxel, ABRAXANE * In a subset of 12 patients with head and neck cancer where SPARC ...
- PR Newswire (press release),
FDA Accepts ERBITUX(R) (Cetuximab) sBLA Submission for the ... Oct 31, 2005
The application seeks approval for use of ERBITUX in combination with radiation for locally or regionally advanced head and neck cancer, and as monotherapy in ...
- Business Wire (press release),
Briggs doesn't regret that he kept on coaching Nov 11, 2005
Faced with giving up football while recovering from surgery, radiation treatment and chemotherapy for head and neck cancer, Briggs, Western Carolina's head ...
- Winston-Salem Journal,
Viventia Biotech Reports Third Quarter 2005 Results Nov 15, 2005
Proxinium(TM) is entering Phase II clinical trials for the treatment of head and neck cancer, and Vicinium(TM) is currently enrolling patients in a Phase I/II ...
- PharmaLive.com (press release),
Spectrum Pharmaceuticals Reports Third Quarter 2005 Financial and ... Nov 4, 2005
...of 2005. * Plans are underway to initiate a Phase 2 study in head and neck cancer and other pilot combination studies. Ozarelix ...
- PR Newswire (press release),
Expanded use sought for colon cancer drug Nov 1, 2005
...partner Bristol-Myers Squibb say US regulators have accepted their application to market the colon cancer drug Erbitux for the treatment of head and neck cancer ...
- News-Medical.net,
ImClone CEO Quits Nov 11, 2005
The FDA has since approved Erbitux for the treatment of colon cancer. ImClone is also seeking to sell Erbitux as a treatment for head and neck cancer. ...
- Red Herring,
Tumor Protein Highly Predictive to Response to Abraxaneâ„¢ in Head ... Nov 7, 2005
Levels of the albumin-binding protein referred to as SPARC (Secreted Protein Acidic Rich in Cysteine) is highly associated with responses achieved with ...
- Cancer Consultants (press release),
ImClone seeks expanded use for cancer drug Erbitux Oct 31, 2005
Quote, Profile, Research) on Monday said US regulators accepted their application to market colon cancer drug Erbitux for the treatment of head and neck cancer ...
- LaSalute.net,
Study: PET scans underused in some cancers Nov 8, 2005
July 26, 2005) -- A highly powerful scanner combining two state-of-the-art technologies might detect the spread of head and neck cancer more accurately than ...
- Science Daily (press release)
Rheinland-Pfalz Holds Merck KGaA Rating Nov 17, 2005
...following the company's statement saying that a study confirmed its Erbitux drug improves overall survival and locoregional control in head and neck cancer. ...
- New Ratings
Gala Succeeds in Growing Funds and Awareness Nov 10, 2005
...comprehensive care for infants, adolescents and adults born with cleft lip, cleft palate, and conditions stemming from head and neck cancer or craniofacial ...
- PR Newswire (press release),
ENT Conference in Napier Nov 6, 2005
...themes include thyroid cancer, parotid gland surgery, management of tracheal airway problems, and governmental involvement in head and neck cancer,� he says. ...
- Scoop.co.nz (press release),
Dan Family to Take Viventia Biotech Private Nov 14, 2005
Viventia's lead products, Proxinium(TM) is entering Phase II clinical trials for the treatment of head and neck cancer, and Vicinium(TM) is currently enrolling ...
- TechFinance,
SAD 48 comes to teacher's aid Concert set to relieve music ... Nov 10, 2005
Clifford was diagnosed earlier this year with a form of head and neck cancer, and is undergoing a very aggressive form of chemical and radiation treatment at ...
- Bangor Daily News,
Amgen: Cancer therapy slows tumor growth Nov 3, 2005
Panitumumab is also in clinical trials for lung and kidney cancer, while ImClone is investigating Erbitux for head and neck cancer. ...
- BusinessWeek
FDA reviews new use for Erbitux Oct 31, 2005
Colorectal drug from Bristol-Myers and ImClone now being weighed for head and neck cancer treatment. By Aaron Smith, CNN/Money staff writer. ...
- CNN
'Star Trek' spinoff creator Michael Piller dead from cancer at age ... Nov 2, 2005
Star Trek: Deep Space Nine" and the Emmy-nominated "Star Trek: The Next Generation" died Tuesday after a long battle with head and neck cancer, Startrek.com ...
- Reality TV World,
Colleagues Pay Tribute To Trek's Michael Piller Nov 8, 2005
For the past three years, Pillar fought a personal battle against head and neck cancer, but remained that nice guy his colleagues had grown to love. ...
- SyFyPortal,
Colgate buys stake in Introgen Nov 4, 2005
..."Everyone and their brother is focused solely on Advexin for head and neck cancer," Pantginis said. "Today's announcement talks to the depth of the pipeline.". ...
- Austin American-Statesman (subscription),
Biotechnology Can Transform Medicine, Health Care, Expert Says Oct 27, 2005
...cancer. The Chinese government recently approved the first marketed gene transfer for treatment of head and neck cancer. Scientists ...
- Washington File,
Smoking Should be Assessed in Cancer Trials Nov 1, 2005
...on smoking history and status during or after treatment unless the disease is considered to be smoking related, such as lung or head and neck cancer, Gritz says ...
- CancerWise
Wellness calendar Nov 8, 2005
Cancer meeting: The oral, head and neck cancer support group will meet from 7 to 9 pm in Indianapolis-Marion County Public Library, Nora branch, 8625 Guilford ...
- Indianapolis Star,
Free cancer exam offered Nov 7, 2005
By Christine Steele. For the seventh year in a row, Dr. Sarvjit Gill and area doctors and nurses are offering a free head and neck cancer screening. ...
- Loveland Herald Reporter,
Abgenix Plans BLA Filing On Robust Panitumumab Results Nov 3, 2005
Erbitux also is being developed for lung, pancreatic and ovarian cancers, and ImClone recently filed an sBLA for Erbitux to treat head and neck cancer. ...
- BioWorld Online (subscription),
US Stocks Head for Biggest 2-Day Gain in a Year on Oil, Deals Oct 31, 2005
The Food and Drug Administration granted a priority review of Erbitux for use against head and neck cancer, ImClone and Bristol-Myers Squibb Co., which co ...
- Bloomberg
Health calendar Oct 25, 2005
248-656-0120, 10 am- 2 pm weekdays. Head and neck cancer support: Education and support, friends and families welcome, 6:30-8:30 pm Thu. ...
- Detroit Free Press,
TV Tidbits Michael Piller, UNC-CHalum and Star Trek producer, dies ... Nov 3, 2005
..."Piller, who produced more than 500 hours of Star Trek, had struggled with an aggressive form of head and neck cancer but kept his condition private from many ...
- Winston-Salem Journal,
Merck KGaA Q3 net surges 57 pct on liquid crystals, hikes FY sales ... Oct 25, 2005
Merck wants to expand the indicated uses of the drug to earlier stages of colorectal cancer, non-small-cell lung cancer and for head and neck cancer. ...
- Forbes
US Stocks Rise on Optimism About Economy; Wal-Mart Gains Oct 31, 2005
The FDA granted a priority review of Erbitux for use against head and neck cancer, ImClone and Bristol-Myers Squibb Co., which co-markets Erbitux, said. ...
- Bloomberg
US Stock-Index Futures Rise; Chiron, Placer Dome Advance Oct 31, 2005
The US Food and Drug Administration granted a priority review of Erbitux for use against head and neck cancer, ImClone and Bristol-Myers Squibb Co., which co ...
- Bloomberg
Gene Therapy in a Bottle of Mouthwash Nov 6, 2005
The company's most advanced drug, which is in late-stage clinical trials, is a treatment for head and neck cancer that it hopes will be the first gene therapy ...
- New York Times,
Imclone Revisited Oct 27, 2005
They're trying for new markets, such as head and neck cancer, but these are small ones, and you have to figure that there's off-label use going on already in ...
- Corante
Star Trek spin-off creator dies Nov 2, 2005
Michael Piller, who co-created numerous Star Trek spin-off series and wrote the movie Star Trek: Insurrection, has died aged 57 from head and neck cancer. ...
- BBC News,
Queen takes a closer look at new hospital Oct 27, 2005
They then visited the 12 operating theatres where they were shown equipment used by head and neck cancer surgeon Paul O'Flynn, who lives in Hampstead. ...
- Broadway 24,
Trek's Piller To Be Honored In Public Memorial Nov 4, 2005
Piller, who was 57, died early on Tuesday, November 1, at his home following an extended battle with head and neck cancer. to follow at the same location. ...
- SyFyPortal,
Ethyol® Allows Greater Tolerability of Chemotherapy in Head and ... Sep 29, 2005
In the pivotal trial involving patients with head and neck cancer, Ethyol reduced the incidence of xerostomia but had no effect on the incidence or severity of ...
- Cancer Consultants (press release),
Ethyol® Allows Greater Tolerability of Chemotherapy in Head and ... Sep 27, 2005
...in the journal Cancer, the cytoprotective agent Ethyol® (amifostine) may allow for greater delivery of chemotherapy in the treatment of head and neck cancer. ...
- Cancer Consultants (press release),
Radiosensitizer May Benefit Head and Neck Cancer Patients Sep 6, 2005
According to a study published in the journal The Lancet Oncology, head and neck cancer patients with low oxygen levels in their cancer cells have a better ...
- Cancer Consultants (press release),
Radiation depresses head, neck cancer patients Sep 23, 2005
...and longitudinal studies have looked at the impact that this treatment modality can have on the long-term quality of life of head and neck cancer survivors. ...
- myDNA.com,
Prediction of Treatment Response in Head and Neck Cancer by ... Sep 30, 2005
Treatment of head and neck cancer could be improved and perhaps standardized if reliable markers for tumor progression and poor prognosis could be developed. ...
- Am J Neuroradiology (subscription)
Predicting Response of Head and Neck Cancer to Accelerated ... Aug 30, 2005
...proliferation and survival. Approximately 40,000 people in the United States are diagnosed with head and neck cancer every year. Cancers of ...
- Cancer Consultants (press release),
Additional Treatment for Head and Neck Cancer Aug 30, 2005
...(Ivanhoe Newswire) -- A new predictor could help identify head and neck cancer patients who could benefit from an additional drug during radiotherapy ...
- Ivanhoe
Danish scientists have identified which head and neck cancer ... Aug 30, 2005
Danish scientists have identified which head and neck cancer patients will benefit from additional drug treatment during radiotherapy, in a paper published ...
- News-Medical.net,
Merck KGaA and Takeda to Co-Develop and Co-Promote Matuzumab ... Sep 29, 2005
Merck submitted applications to the EMEA and Swissmedic on August 30, 2005, for the use of Erbitux to treat head and neck cancer. ...
- PharmaLive.com (press release),
GenVec invests $15M from stock sale into drug Sep 30, 2005
...tumor types. We expect to expand our studies of treating melanoma, head and neck cancer, breast and others,� he said. Earlier ...
- Business Gazette,
Viventia receives FDA clearance to initiate Phase II cancer trial ... Sep 19, 2005
FDA) to begin a Phase II study evaluating Proxinium(TM) for the treatment of patients with chemotherapy-refractory recurrent head and neck cancer. ...
- Canada NewsWire (press release),
Head, Neck Disorders Resulting from Iranian-Iraqi Conflict ... Sep 22, 2005
...and head and neck (16.2 percent). Three patients presented with head and neck cancer . Seven patients were diagnosed with mostly ...
- Newswise (press release)
Study Results of Novel Inovio Electroporation Device for Gene ... Sep 27, 2005
Inovio is moving its lead product, the MedPulser(R), through pre-marketing studies for head and neck cancer and skin cancers in Europe, where it has CE Mark ...
- Business Wire (press release),
High Osteopontin Levels Predict Nimorazole Response with Head and ... Sep 1, 2005
...a marker for tissue hypoxia, can predict whether the radiosensitizing agent nimorazole will be useful in patients with head and neck cancer, new research ...
- Cancerpage.com,
Supplements for cancer patients may do harm Sep 26, 2005
A separate vitamin E study showed head-and-neck-cancer patients who took the supplement increased their risk for developing a second cancer. ...
- Naples Daily News (subscription),
Epivir®-HBV Reduces Reactivation of Hepatitis B in Nasopharyngeal ... Sep 27, 2005
...chemotherapy. Nasopharyngeal cancer, a type of head and neck cancer, originates in the the nose and back of the throat. Standard ...
- Cancer Consultants (press release),
UPDATE 3-ImClone seeks Erbitux approval in head/neck cancer Aug 30, 2005
...(IMCL.O: Quote, Profile, Research) said on Tuesday it was seeking US regulatory approval to use colon cancer drug Erbitux in head and neck cancer after a ...
- Reuters
Merck applies to use Erbitux for head, neck cancer Aug 30, 2005
Research) has applied to extend the use in Europe of its colorectal cancer treatment Erbitux, its main drug hope for the future, for head and neck cancer. ...
- Reuters
ImClone Seeks Erbitux OK for Head, Neck Cancer Aug 30, 2005
IMCL) said on Tuesday it is seeking US regulatory approval for use of colon cancer drug Erbitux (search) in head and neck cancer after a previous filing delay. ...
- FOX News
Delays in cancer drugs approval causing deaths of NHS patients ... Sep 19, 2005
...delayed are Letrozole for breast cancer, Irinotecan, Bevacizumab and Cetuximab for advanced colon cancer, Cetuximab for head and neck cancer and Gemcitabine ...
- The Observer,
Vitamin's effect on cancer varies by smoker status Sep 20, 2005
...cancer occurrence. During follow-up, 700 women developed tobacco-related cancers, such as lung cancer or head and neck cancer. Among ...
- ABC News
Anti-Oxidant Supplements May Increase Risk of Cancer Recurrence Sep 21, 2005
...alpha-tocopherol and beta-carotene could reduce the rate and severity of acute adverse effects of radiation therapy in 540 patients with head and neck cancer. ...
- Cancerpage.com,
Northwest Biotherapeutics Announces Clinical Advisory Board for ... Sep 20, 2005
...the planned Phase II clinical trial of DCVax(R)-Brain and the planned Phase I clinical trial for non-small cell lung cancer and head and neck cancer, and the ...
- PR Newswire (press release),
Drugs in Development Sep 13, 2005
..."We are particularly excited by Erbitux not only in the treatment of colorectal cancer but also in its potential in head and neck cancer, and by BLP25 Liposome ...
- R&D Directions (subscription),
... Go to the Article Sep 8, 2005
...grant from the Department of Defense, MD Anderson is conducting a clinical trial to increase screening of lung cancer and head and neck cancer survivors, and ...
- CancerWise
Viventia shares rise 15% after FDA clearance for Phase 2 cancer ... Sep 19, 2005
...has received US Food and Drug Administration approval to begin a Phase 2 evaluation of its lead drug Proxinium, a treatment for head and neck cancer. ...
- National Post,
Radiation scare puts patients off Sep 15, 2005
...medical adviser, Dr Jane Maher, a consultant oncologist at Mount Vernon Cancer Centre in Middlesex, adds: "Colleagues in head and neck cancer, in particular ...
- Telegraph.co.uk,
ImClone Systems Incorporated and Bristol-Myers Squibb File ... Aug 30, 2005
About Head and Neck Cancer According to the American Cancer Society, approximately 40,000 Americans will be diagnosed with head and neck cancer this year ...
- PR Newswire (press release),
Inovio Biomedical Awarded $1 Million by US Department of Defense ... Sep 13, 2005
...for head and neck and skin cancers in Europe, where it has CE Mark accreditation, a US Phase III pivotal study for recurrent head and neck cancer, and a Phase ...
- Business Wire (press release),
Strategy Helps Tailor Head, Neck Cancer Treatment Aug 30, 2005
30 (HealthDay News) -- Scientists have discovered a way to determine which head and neck cancer patients would benefit from additional drug treatment during ...
- HealthCentral.com
ImClone Systems Incorporated and Bristol-Myers Squibb File ... Aug 30, 2005
According to the American Cancer Society, approximately 40,000 Americans will be diagnosed with head and neck cancer this year, including cancers of the tongue ...
- PharmaLive.com (press release),
After Two Decades, New Hope For Drugs That Target Cancer Sep 9, 2005
...new targeted therapy. Introgen Therapeutics (INGN) has a promising drug to help treat head and neck cancer, Gilbertson says. If it ...
- Investor's Business Daily (subscription)
New Research at Meeting of Ear, Nose, and Throat Specialists in ... Sep 11, 2005
...including: otitis media and cochlear implants, snoring and sleep apnea, battlefield head and neck injuries, sinusitis, hearing loss, and head and neck cancer. ...
- Newswise (press release)
Neighbor’s death inspires children’s fundraiser Sep 3, 2005
...all medical options. Charged by this knowledge, the kids set out to raise money for research of head and neck cancer. While Morgan ...
- Kansas City Star,
: ASTRO Elects New Officers for 2006 Sep 2, 2005
In addition, he is Co-director of the Institute for Head and Neck Cancer and a Professor of Radiation Oncology at the Albert Einstein College of Medicine in ...
- NewsReleaseWire.com (press release)
Acclaimed surgeon and professor joins Center for Healthcare ... Sep 10, 2005
...and surgeon who devoted the first 20 years of his professional career to leading the development of innovative surgical treatments for head and neck cancer. ...
- AME Info,
Cash cuts made sluggish system slower Sep 13, 2005
So it is that irinotecan, bevacizumab and cetuximab for advanced colon cancer, cetuximab for head and neck cancer and gemcitabine and rubetican for pancreatic ...
- Times Online,
Review of the First Commercially Approved Gene Therapy Product ... Sep 9, 2005
The broad-based use of this product for head and neck cancer in China will yield very useful information, which we look forward to hearing more about.". ...
- Business Wire (press release),
ImClone Seeks Erbitux OK for Head, Neck Tumors Aug 30, 2005
NEW YORK -(Dow Jones)- ImClone Systems Inc. (IMCL) and its partners are seeking marketing approval to use Erbitux as a treatment of head and neck cancer. ...
- Smartmoney.com (subscription)
MIDDAY BIZ REPORT: Sprint buys affiliates Aug 30, 2005
...today said it has submitted an application to US regulators to expand the approval of its Erbitux cancer treatment to include head and neck cancer, meeting a ...
- Kansas City Star,
Erbitux’s Next Round Aug 30, 2005
Analysts expect ImClone Systems’ drug Erbitux to be successful in its FDA application as a treatment for head and neck cancer. ...
- Red Herring,
Merck KGaA seeks approval of Erbitux in combination with radiation ... Aug 30, 2005
...an application to the European Medicines Agency (EMEA) and Swissmedic to extend the use of cancer drug Erbitux to treat head and neck cancer in combination ...
- Forbes
Protein spells help in cancer fight Aug 30, 2005
30 (UPI) -- The protein osteopontin shows which patients with head and neck cancer would benefit from drugs in addition to radiotherapy, Danish researchers say ...
- United Press International
Biocon to invest Rs. 750 crore in three years Sep 3, 2005
Mazumder-Shaw said the company, currently conducting pre-clinical studies with immuno therapy for head and neck cancer patients, was expected to come to the ...
- Malayala Manorama,
ImClone Sends A 'Dear Doctor' Letter Sep 16, 2005
Other upcoming milestones include approval of the drug to treat head and neck cancer by the end of the year and data in colon, lung, and pancreatic cancer in ...
- Forbes
Merck KGAA seeks extension of Erbitux for treatment of head and ... Aug 31, 2005
...applied to the European Medicines Agency and Swissmedic for the extension of the use of its colorectal cancer treatment drug, Erbitux, for head and neck cancer ...
- New Ratings
SD Biotechs Playing the Name Change Game Sep 10, 2005
Its electroporation therapy system, which aims to target only unhealthy cells, is in late-stage studies for head and neck cancer.
- San Diego Business Journal (subscription),
Lectures to be the talk of the town Sep 7, 2005
The series kicks off on October 6 with Professor Arnold Maran, a head and neck cancer surgeon, who will explain how the voice works. ...
- Scotsman,
Catamounts shock No. 2 Furman Sep 11, 2005
Lord for allowing me to be on the sidelines and help coaching this team to a big victory,� said WCU coach Kent Briggs, who is battling head and neck cancer. ...
- Asheville Citizen-Times,
Business news in brief from around New Jersey Aug 30, 2005
...manufacturing and other facilities in Branchburg, said Tuesday the application seeks US marketing approval for Erbitux to treat advanced head and neck cancer. ...
- Miami Herald,
FDA allows late-stage BioAlliance antifungal trial Sep 7, 2005
...part of the IND filing, BioAlliance submitted the results of two completed phase III trials conducted in the EU, one in head and neck cancer patients following ...
- Pharmaceutical Business Review
Biocon to double its manpower Sep 5, 2005
Biocon is currently focusing on head and neck cancer.Biocon claimed it was moving ahead satisfactorily in oral insulin research. ...
- Financial Express,
Biocon set to hire 2,000 more in 2 years Sep 4, 2005
Human clinical trials were being carried out in multiple clinics in the country. Biocon is currently focusing on head and neck cancer. ...
- Rediff,
Advocate Good Samaritan Hospital in Chicagoland First to Offer ... Aug 30, 2005
...normal structures that should be spared from the radiation--such as treating prostate cancer to spare the rectum and bladder; head and neck cancer to spare the ...
- U.S. Newswire (press release),
Option Activity Watch: ImClone Systems, DR Horton, and Western ... Aug 31, 2005
...garnering attention after announcing that it is seeking approval from the Food and Drug Administration to use Erbitux for the treatment of head and neck cancer ...
- Schaeffers Research,
AROUND THE NATION Aug 30, 2005
ImClone Systems said that it submitted an application to US regulators to expand the approval of its Erbitux cancer treatment to include head and neck cancer. ...
- Houston Chronicle,
Action, EGL, Hutchinson, Immucor, ViaCell: US Equity Preview Aug 30, 2005
...(BMY US) said in a statement that ImClone has asked US regulators to approve the drug to treat a form of head and neck cancer. Immucor Inc. ...
- Bloomberg
Business news in brief Aug 31, 2005
...said it had submitted an application to federal regulators to expand the approval of its Erbitux cancer treatment to include head and neck cancer, meeting a ...
- Philadelphia Inquirer,
Big Movers in the Stock Market Aug 30, 2005
Imclone and its partner, Bristol-Myers, are seeking Food and Drug Administration marketing approval to use colon cancer Erbitux for head and neck cancer. ...
- Washington Post,
Insurers Could See $26 Billion in Katrina Claims Aug 30, 2005
The application seeks US marketing approval for the use of ERBITUX in combination with radiation for advanced head and neck cancer cases, among other things. ...
- BusinessWeek
Imclone, Bristol seek new use for Eribitux Aug 30, 2005
Squibb Co.(BMY.N: Quote, Profile, Research) said on Tuesday they are seeking US regulatory approval for use of its Erbitux cancer drug in head and neck cancer. ...
- Reuters
Market Highlights Aug 30, 2005
...and its partner Bristol-Myers are asking for marketing approval from the Food and Drug Administration to use colon-cancer drug Erbitux for head and neck cancer ...
- Winston-Salem Journal,
Southern Conference Football Notebook Western Carolina's Briggs is ... Aug 30, 2005
Briggs endured seven weeks of chemotherapy and radiation treatment this summer after surgery for head and neck cancer. He said yesterday that he's ready to go. ...
- Winston-Salem Journal,
ImClone Boosted By Upbeat Erbitux Royalties Outlook Aug 30, 2005
Squibb (nyse: BMY - news - people ) submitted supplemental biologics license application for Erbitux to treat squamous cell head and neck cancer, within the ...
- Forbes
Hot Stocks: WMT DY EASI LSTR ATN ISCA TRK AMLN ATYT -2- Aug 30, 2005
...company, with its partner Bristol-Myers Squibb Co., seeks Food and Drug Administration marketing approval to use Erbitux as a treatment of head and neck cancer ...
- Yahoo News
US stocks slide as storm's damage toll weighs Aug 30, 2005
...rose 32 cents to $32.92 on the Nasdaq after the company said it is seeking US regulatory approval to use its Erbitux drug in treatment of head and neck cancer. ...
- Reuters.uk,
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Head and Neck Cancer
you may want to try searching the Internet using the Google search box below.
|
|
|
